About this trial
SUNRISE aims to create a comprehensive, engaging, and sustainable digital health promotion program that not only addresses immediate health behaviours but also instills lifelong healthy habits among adolescents. By integrating cutting-edge digital tools with traditional educational settings, SUNRISE seeks to bridge the gap between knowledge and practice, making cancer prevention a tangible and achievable goal for young people. This study represents a significant step towards reducing the future burden of cancer through early and innovative preventive measures.
The SUNRISE project aims to test its interventions on students across eight European countries, including Greece, Switzerland, Slovenia, Spain, Cyprus, Italy, Belgium, and Romania. This study focuses on integrating a unique, digitally enhanced program combining different digital solutions with new methods to change adolescent health behaviour through social media campaigns, social bot platforms, educational games, and health-related advertising content into the school environment, targeting students aged 10 to 19 years.
The program emphasizes inclusivity, ensuring participation from both urban and rural regions and socially disadvantaged groups such as ethnic minorities and migrants. By addressing diverse socio-economic, cultural, and environmental contexts, SUNRISE aspires to create a universally applicable and impactful intervention.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Minimum Age: Students must be at least 10 years old at the time of enrolment.
Devices and Internet Access: Students must have access to an electronic device with Internet connectivity.
Informed Consent: Students must provide their signed informed consent to participate in the study.
Parental Consent: Students, when necessary, must obtain and submit signed informed consent from a parent or legal guardian.
Disqualifiers
Age Restrictions: Students who are younger than 10 years or older than the established age range for participation.
Consent Issues: Students who have not signed the informed consent form or do not have signed informed consent from their parents or legal guardians.
Follow-up Limitations: Students who are unable to commit to the follow-up period of at least 18 months or are unlikely to complete the study.
Trial population
Secondary and upper secondary students between 10 and 19 years old (at time of recruitment), who are freely willing to participate in the study.
Trial design
Other
Prospective
Treatments tested in this trial
SUNRISE program
Other interventionThe program will use several solutions, each focusing on different aspects of health promotion: * SmartCoach, a mobile phone-based life-skills training program, focuses on self-management, social skills, and substance use resistance. * Social robots and conversational assistants aim to engage students through interactive sessions on health topics like diet and physical activity. * Educational and serious games enhance knowledge and resistance to unhealthy food marketing, providing an engaging way to learn about advertising tactics and healthy eating. * The influencer campaign tackles nutritional misinformation by using content created by influencers to educate adolescents on detecting and critically evaluating misleading health information. * Health and advertisement educational module aims to educate students on recognizing deceptive advertising and making informed choices about their health.
Treatment groups
Trial outcomes
Primary outcomes
Feasibility of the Digitally-Enhanced Program
This will be measured by evaluating the usage and engagement with the intervention, through a in-house authoring and monitoring tool. This tool will include the questionnaires, statistical displays, interactive visualization of data and reporting tools for monitoring and assessment of the intervention outcomes.
Secondary outcomes
Frequency of tobacco cigarette smoking
Determined by the number of days on which tobacco cigarettes were smoked in the last 30 days
Prevalence and frequency of other nicotine products use
Determined by the number of days on which other nicotine products, e.g., vape, e-cigarette, e-shisha, snus or nicotine pouches, were consumed in the last 30 days
Prevalence and frequency of cannabis use
Measured by the number of cannabis (containing THC) consumption days in the preceding 30 days
Prevalence and frequency of alcohol use
Assessed by the number of alcohol use days in the preceding 30 days
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Biobizkaia Health Research Institute
Lead sponsor
FEDERAZIONE ITALIANA DELLE ASSOCIAZIONI DI VOLONTARIATO IN ONCOLOGIA
Collaborator
Hellenic Mediterranean University
Collaborator
University Ghent
Collaborator
University of Zurich
Collaborator
FISABIO (Foundation for the Promotion of Healthcare and Biomedical Research in the Valencian Community)
Collaborator
The Oncology Institute "Prof. Dr. Ion Chiricuţă" Cluj-Napoca
Collaborator
Cyprus Association of Cancer Patients and Friends (PASYKAF)
Collaborator
Alma Mater Europaea University
Collaborator
This trial is not recruiting at the moment. You can still explore other options: